SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-299534
Filing Date
2014-08-07
Accepted
2014-08-07 08:01:14
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d736146d10q.htm 10-Q 356520
2 EX-31.1 d736146dex311.htm EX-31.1 8130
3 EX-31.2 d736146dex312.htm EX-31.2 8175
4 EX-32.1 d736146dex321.htm EX-32.1 4461
  Complete submission text file 0001193125-14-299534.txt   3495310

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT omed-20140630.xml EX-101.INS 450474
6 XBRL TAXONOMY EXTENSION SCHEMA omed-20140630.xsd EX-101.SCH 42332
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20140630_cal.xml EX-101.CAL 49404
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20140630_def.xml EX-101.DEF 138368
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20140630_lab.xml EX-101.LAB 324098
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20140630_pre.xml EX-101.PRE 235504
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 141021802
SIC: 2834 Pharmaceutical Preparations